FIM
SCMP

Freedom Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Freedom Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-38,713
Closed -$695K – 1256
2017
Q4 		$695K Sell
38,713
-1,938
-5% -$23.9K 0.04% 498
2017
Q3 		$480K Buy
40,651
+9,012
+28% +$101K 0.03% 614
2017
Q2 		$332K Sell
31,639
-20,156
-39% -$205K 0.02% 743
2017
Q1 		$570K Buy
51,795
+32,655
+171% +$379K 0.03% 503
2016
Q4 		$259K Buy
+19,140
New +$267K 0.02% 762

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Freedom Investment Management's SCMP Position: Q1 2018 in Review

Freedom Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 38,713 shares — an estimated $695K sold.

Freedom Investment Management first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $695K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Freedom Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Freedom Investment Management sold 38,713 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $695K.
  • Freedom Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
  • Freedom Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $695K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Freedom Investment Management's 13F filing for Q1 2018, filed 6 Apr 2018.